ARCHIVES

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

This article is from The Cancer Letter archive.

Vol. 19 No. 34 | September 3, 1993

Download PDF Visit The Full Archive

Related Articles

Prevention Program Being Developed For Primary Providers

January 29, 1988

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

In Brief: PCORI Forms Clinical Trials Advisory Board

April 4, 2014

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

Large, Conclusive Trials Provide Answers To Treatment Questions For GI Cancers

June 26, 2009

NCAB To Hear Reports On Environmental Carcinogenesis, International Research Efforts

June 4, 1976